Clinical Trial Update: Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue

View source ↗

Summary

A completed clinical trial assessed intraoperative mapping of regional lymphatics draining the primary site of melanoma using the blue dye isosulfan blue.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Lymphazurin (isosulfan blue)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Melanoma | Status: COMPLETED